Role of microRNAs in endocrine cancer metastasis

Cilene Rebouças Lima1, Cibele Crastequini Gomes1, Marinilce Fagundes Santos1

  • 1Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, Avenida Professor Lineu Prestes 1524, Prédio I, CEP 05508-000, São Paulo, SP, Brazil.

Insights

MicroRNAs (miRNAs) play a crucial role in cancer metastasis, acting as either pro-metastatic or anti-metastatic factors. Understanding these microRNAs and their functions offers potential for novel therapeutic targets in endocrine cancers.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) deregulation is implicated in human diseases, including cancer.
  • Cancer metastasis significantly complicates treatment and worsens prognosis.
  • The role of miRNAs in cancer progression and metastasis is increasingly recognized.

Purpose of the Study:

  • To review the discovery and functions of miRNAs in endocrine cancer metastasis.
  • To highlight the regulatory roles of miRNAs in the metastatic cascade.
  • To identify potential novel therapeutic targets based on miRNA functions.

Main Methods:

  • Literature review of studies on miRNAs in endocrine cancer metastasis.
  • Focus on miRNAs with identified targets and established functions.
  • Analysis of upstream regulation of key miRNAs.

Main Results:

  • miRNAs are involved in distinct metastatic steps like EMT, migration, invasion, and colonization.
  • Specific miRNAs are underexpressed (e.g., miR-200s, miR-126) or overexpressed (e.g., miR-21, miR-183) in endocrine cancers.
  • Some miRNAs in serum exosomes show potential as diagnostic tools.

Conclusions:

  • miRNAs are critical regulators of endocrine cancer metastasis.
  • Further research into functional miRNA studies is essential for endocrine cancers.
  • Targeting specific miRNAs may offer novel therapeutic strategies for cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K